E
Eva Schnabel
Researcher at Ludwig Maximilian University of Munich
Publications - 10
Citations - 225
Eva Schnabel is an academic researcher from Ludwig Maximilian University of Munich. The author has contributed to research in topics: Population & FEV1/FVC ratio. The author has an hindex of 8, co-authored 10 publications receiving 209 citations.
Papers
More filters
Journal ArticleDOI
Prospective association between food sensitization and food allergy: results of the LISA birth cohort study
Eva Schnabel,Stefanie Sausenthaler,B. Schaaf,Torsten Schäfer,Irina Lehmann,Heidrun Behrendt,Olf Herbarth,Michael Borte,Michael Borte,Ulrich Kramer,A. von Berg,Heinz Erich Wichmann,Joachim Heinrich +12 more
TL;DR: This research focuses on the development of early and efficient markers for later development of food allergy in children aged 6-18 months.
Journal ArticleDOI
Respiratory tract infections and not paracetamol medication during infancy are associated with asthma development in childhood.
Eva Schnabel,Joachim Heinrich +1 more
Journal ArticleDOI
Association between lung function, hypertension and blood pressure medication
TL;DR: It is speculated that high blood pressure in combination with antihypertensive treatment and not HBP itself might be associated with reduced lung function in a general adult population.
Journal ArticleDOI
Burden of otitis media and pneumonia in children up to 6 years of age: results of the LISA birth cohort
Eva Schnabel,Stefanie Sausenthaler,Inken Brockow,Johannes G. Liese,Olf Herbarth,Borte Michael,Borte Michael,Beate Schaaf,Ursula Krämer,Andrea von Berg,H.-Erich Wichmann,Joachim Heinrich +11 more
TL;DR: An analysis of the prevalence, first episode proportions and recurrence of childhood infection diseases in selected regions of Germany in children up to 6 years of age shows that infectious diseases, especially otitis media, are very frequent childhood diseases in Germany.
Journal ArticleDOI
High blood pressure, antihypertensive medication and lung function in a general adult population
Eva Schnabel,Stefan Karrasch,Holger Schulz,Sven Gläser,Christa Meisinger,Margit Heier,Annette Peters,H-Erich Wichmann,Jürgen Behr,Rudolf M. Huber,Joachim Heinrich +10 more
Abstract: Background: Several studies showed that blood pressure and lung function are associated. Additionally, a potential effect of antihypertensive medication, especially beta-blockers, on lung function has been discussed. However, side effects of beta-blockers have been investigated mainly in patients with already reduced lung function. Thus, aim of this analysis is to determine whether hypertension and antihypertensive medication have an adverse effect on lung function in a general adult population. Methods: Within the population-based KORA F4 study 1319 adults aged 40-65 years performed lung function tests and blood pressure measurements. Additionally, information on anthropometric measurements, medical history and use of antihypertensive medication was available. Multivariable regression models were applied to study the association between blood pressure, antihypertensive medication and lung function. Results: High blood pressure as well as antihypertensive medication were associated with lower forced expiratory volume in one second (p = 0.02 respectively p = 0.05; R 2 : 0.65) and forced vital capacity values (p = 0.01 respectively p = 0.05, R 2 : 0.73). Furthermore, a detailed analysis of antihypertensive medication pointed out that only the use of beta-blockers was associated with reduced lung function, whereas other antihypertensive medication had no effect on lung function. The adverse effect of beta-blockers was significant for forced vital capacity (p = 0.04; R 2 : 0.65), while the association with forced expiratory volume in one second showed a trend toward significance (p = 0.07; R 2 : 0.73). In the same model high blood pressure was associated with reduced forced vital capacity (p = 0.01) and forced expiratory volume in one second (p = 0.03) values, too. Conclusion: Our analysis indicates that both high blood pressure and the use of beta-blockers, but not the use of other antihypertensive medication, are associated with reduced lung function in a general adult population.